Less than 15% of veterans with cirrhosis receive alcohol use disorder treatment

Most veteran with cirrhosis and coexisting alcohol-use disorder did not receive behavioral or pharmacotherapy treatment for alcohol use during 6 months of follow-up, according to data published in Hepatology.
“Despite the importance of treating alcohol use disorder (AUD) in the context of cirrhosis, relatively little work has assessed the uptake of evidence-based AUD treatments in patients with this common disorder,” Shari S. Rogal, MD, MPH, from the VA Pittsburgh Healthcare System, and colleagues wrote. “Behavioral therapies are considered to be the cornerstone of AUD

Source link

Related posts

Enrollment begins for phase 2a trial of hepatic encephalopathy therapy


Akero begins screening for phase 2a trial of NASH therapeutic


Sibling donation of FMT linked to long-term UC remission


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy